Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study
Summary Background Compared with administration in the catheterization laboratory, early treatment with glycoprotein IIb/IIIa inhibitors provides benefits to patients with ST-segment elevation myocardial infarction who undergo primary percutaneous intervention. Whether…
